BCG immunotherapy of bladder cancer: 20 years on

Lancet. 1999 May 15;353(9165):1689-94. doi: 10.1016/S0140-6736(98)07422-4.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • BCG Vaccine / therapeutic use*
  • Cytokines / physiology
  • Cytotoxicity, Immunologic
  • Humans
  • Immunity, Cellular
  • Immunotherapy, Active*
  • T-Lymphocytes / immunology
  • Treatment Outcome
  • Urinary Bladder Neoplasms / therapy*

Substances

  • BCG Vaccine
  • Cytokines